$12.33
0.928.06%
At close: Dec 15, 4:00 PM EST
$12.18
-0.15-1.22%
After Hours: 5:34 PM EST
Comments
Loading...
Emergent BioSolutions Stock Guidance | NYSE:EBS | Benzinga
Emergent BioSolutions issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/29/2025 | EBS | Emergent BioSolutions | FY | 2025 | — | — | — | $775.00M | $835.00M | $795.90M | Get Alert |
| 08/06/2025 | EBS | Emergent BioSolutions | FY | 2025 | — | — | — | $765.00M | $835.00M | $826.35M | Get Alert |
| 05/07/2025 | EBS | Emergent BioSolutions | FY | 2025 | — | — | — | $750.00M | $850.00M | $819.44M | Get Alert |
| 03/03/2025 | EBS | Emergent BioSolutions | FY | 2025 | — | — | — | $750.00M | $850.00M | $1.13B | Get Alert |
| 11/06/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $1.06B | $1.13B | $1.12B | Get Alert |
| 08/06/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $1.05B | $1.13B | $1.03B | Get Alert |
| 08/06/2024 | EBS | Emergent BioSolutions | Q3 | 2024 | — | — | — | $265.00M | $315.00M | $312.15M | Get Alert |
| 05/01/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $1.00B | $1.10B | $1.02B | Get Alert |
| 05/01/2024 | EBS | Emergent BioSolutions | Q2 | 2024 | — | — | — | $160.00M | $210.00M | $244.50M | Get Alert |
| 03/06/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $900.00M | $1.10B | $1.18B | Get Alert |
| 03/06/2024 | EBS | Emergent BioSolutions | Q1 | 2024 | — | — | — | $200.00M | $250.00M | $185.40M | Get Alert |
| 01/09/2024 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.00B | $1.10B | $1.06B | Get Alert |
| 11/08/2023 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.00B | $1.10B | $1.05B | Get Alert |
| 08/08/2023 | EBS | Emergent BioSolutions | Q3 | 2023 | — | — | — | $210.00M | $250.00M | $326.87M | Get Alert |
| 05/09/2023 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.10B | $1.20B | $1.13B | Get Alert |
| 02/27/2023 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.10B | $1.20B | $1.18B | Get Alert |
| 01/09/2023 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.10B | $1.12B | $1.09B | Get Alert |
| 11/08/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.05B | $1.10B | $1.20B | Get Alert |
| 08/01/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.15B | $1.25B | $1.23B | Get Alert |
| 08/01/2022 | EBS | Emergent BioSolutions | Q3 | 2022 | — | — | — | $230.00M | $270.00M | $301.17M | Get Alert |
| 02/24/2022 | EBS | Emergent BioSolutions | Q1 | 2022 | — | — | — | $280.00M | $310.00M | $313.87M | Get Alert |
| 02/24/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.30B | $1.40B | $1.44B | Get Alert |
| 01/09/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.40B | $1.50B | $1.44B | Get Alert |
| 01/09/2022 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.77B | $1.79B | $1.70B | Get Alert |
FAQ
Q
What is the most recent guidance for Emergent BioSolutions (EBS)?
A
There have been no specific sales or earnings guidance reported for Emergent BioSolutions in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved